This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

United Therapeutics Corporation (UTHR)

NASDAQ: Health Care

Get a 5-page Ratings Report on (UTHR) now
$96.20
04/17/14 - 3:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.12B 916.08M 743.18M 603.83M
Cost of Sales 82.77M 76.48M 44.54M 36.13M
Gross Operating Profit 1.03B 839.59M 698.65M 567.70M
Selling, General, and Administrative Expenses 394.01M 201.75M 156.48M 199.60M
Research & Development 299.35M 173.39M 180.02M 166.76M
Operating Income before D & A (EBITDA) 340.86M 464.46M 362.15M 201.34M
Depreciation & Amortization 48.36M 42.81M 44.37M 37.33M
Interest Income 3.83M 3.94M 3.45M 2.94M
Other Income - Net 635.00K 31.87M -629.00K 769.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 296.96M 457.31M 320.48M 167.55M
Interest Expense 18.06M 16.64M 21.37M 19.71M
Pre-Tax Income 278.90M 440.67M 299.12M 147.84M
Income Taxes 104.34M 136.23M 81.87M 41.92M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 174.56M 304.44M 217.24M 105.92M
Net Income From Discontinued Operations 0.00 0.00 625.00K 0.00
Net Income From Total Operations 174.56M 304.44M 217.87M 105.92M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 174.56M 304.44M 217.87M 105.92M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
174.56M 304.44M 217.24M 105.92M
Preferred Dividends
Net Income Available To Common 174.56M 304.44M 217.24M 105.92M
Basic EPS from Continuing Ops. 3.49 5.84 3.80 1.89
Basic EPS from Discontinued Ops. 0.00 0.00 0.01 0.00
Basic EPS from Total Operations 3.49 5.84 3.81 1.89
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.49 5.84 3.81 1.89
Basic Normalized Net Income/Share 3.49 5.84 3.80 1.89
EPS fr Continuing Ops. 3.28 5.71 3.66 1.78
EPS fr Discontinued Ops 0.00 0.00 0.01 0.00
EPS fr Total Ops. 3.28 5.71 3.67 1.78
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.28 5.71 3.67 1.78
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.28 5.71 3.66 1.78
Dividends Paid per Share 0.00 0.00 0.00 0.00
(UTHR) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs